Class Action Settlements are among the most overlooked sources of revenue for busy Corporations. Many executives throw away Class Action notices on the often misguided notion that their claim may be worth but a few pennies. Even the smallest of companies can collect a substantial payment from these settlements, depending upon the magnitude of their purchases of qualifying raw materials, goods or services. Would you be willing to sacrifice a few hours of accounting review for a four, five, or even six figured payment? Let Class Action Settlement House LLC navigate the rough waters of settlement recovery for you, directing you to the hidden gems that may be waiting in your file cabinet. Become a client today!
If you or your company accepted any Visa-Branded Cards and/or MasterCard Branded Cards in the United States at any time from January 1, 2004 to January 25, 2019, you may be entitled to a substantial payment.
Generic Drugs Direct Purchaser Settlement
If you or your company is engaged in the business of the retail sale of automobiles in the United States and use a Dealer Management System ("DMS") or Data Integration Service ("DIS") from CDK Global LLC ("CDK"), or The Reynolds and Reynolds Company ("Reynolds"), you may be entitled to a substantial payment.
This litigation concerns allegations that Toyota designed and sold vehicles with a defective ZF-TRW airbag control unit (ACU). The lawsuit further alleges that certain vehicles which contain this type of ACU are vulnerable to a condition that can cause the vehicles’ airbags and other passenger safety systems to malfunction during a collision, which may result in airbag non-deployment or other safety failures. Toyota denies all claims and the Court has not decided who is right or wrong.
This class action concerns allegations made by Indirect Purchaser Plaintiffs that certain Defendants and their co-conspirators conspired to limit the supply, and fix the prices, of beef with the intent and plan to increase prices of Beef products in the United States.
If you purchased and/or paid for some or all of the price of Suboxone or its AB-rated generic equivalents, you may be eligible for a payment from a class action lawsuit.
Plaintiffs allege that direct purchasers of broadcast television spot advertising were subject to price fixing facilitated by an anticompetitive information exchange between and among certain major television station owners and operators and sales representative firms. As a result, they paid artificially inflated prices for television advertising, in violation of various federal and state laws and are seeking damages for these alleged harms.
Direct purchasers of Lipitor, such as pharmaceutical wholesalers and distributors, allege that Pfizer conspired with Ranbaxy Laboratories Ltd. to delay the release of a cheaper generic version of Lipitor and monopolize the market. Defendants deny these allegations. The parties have reached a $93 million settlement.